YE W, XIE T, SONG Y, et al. The role of androgen and its related signals in PCOS [J]. Journal of cellular and molecular medicine, 2021, 25(4): 1825-1837.
 COONEY L G, DOKRAS A. Cardiometabolic Risk in Polycystic Ovary Syndrome: Current Guidelines [J]. Endocrinology and metabolism clinics of North America, 2021, 50(1): 83-95.
 CIGNARELLA A, MIONI R, SABBADIN C, et al. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS [J]. International journal of molecular sciences, 2020, 21(24):
 DUMESIC D A, OBERFIELD S E, STENER-VICTORIN E, et al. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome [J]. Endocrine reviews, 2015, 36(5): 487-525.
 ROSENFIELD R L, EHRMANN D A. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited [J]. Endocrine reviews, 2016, 37(5): 467-520.
 RODRIGUES J K, NAVARRO P A, ZELINSKI M B, et al. Direct actions of androgens on the survival, growth and secretion of steroids and anti-Müllerian hormone by individual macaque follicles during three-dimensional culture [J]. Human reproduction (Oxford, England), 2015, 30(3): 664-674.
 ROSENFIELD R L, EHRLICH E N, CLEARY R E. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women [J]. The Journal of clinical endocrinology and metabolism, 1972, 34(1): 92-98.
 PHILLIPS T G, SLOMIANY W P, ALLISON R. Hair Loss: Common Causes and Treatment [J]. American family physician, 2017, 96(6): 371-378.
 RITTMASTER R S, LORIAUX D L. Hirsutism [J]. Annals of internal medicine, 1987, 106(1): 95-107.
 AZZIZ R, CARMINA E, DEWAILLY D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J]. Fertility and sterility, 2009, 91(2): 456-488.
 SIRMANS S M, PATE K A. Epidemiology, diagnosis, and management of polycystic ovary syndrome [J]. Clinical epidemiology, 2013, 6(1-13.
 SOKALSKA A, PIOTROWSKI P C, RZEPCZYNSKA I J, et al. Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability [J]. The Journal of clinical endocrinology and metabolism, 2010, 95(12): 5390-5394.
 RAVAL A D, HUNTER T, STUCKEY B, et al. Statins for women with polycystic ovary syndrome not actively trying to conceive [J]. The Cochrane database of systematic reviews, 2011, 10): Cd008565.
 DULEBA A J, BANASZEWSKA B, SPACZYNSKI R Z, et al. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial [J]. Fertility and sterility, 2006, 85(4): 996-1001.
 SCHAIFF R A, MOE R M, KRICHBAUM D W. An overview of cholesterol management [J]. American health & drug benefits, 2008, 1(9): 39-48.
 ALMALKI H H, ALSHIBANI T M, ALHIFANY A A, et al. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials [J]. BMC women's health, 2020, 20(1): 68.
 CARMENA R, BETTERIDGE D J. Diabetogenic Action of Statins: Mechanisms [J]. Current atherosclerosis reports, 2019, 21(6): 23.
 KOCH C A, KRABBE S, HEHMKE B. Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties? [J]. Reviews in endocrine & metabolic disorders, 2018, 19(4): 363-395.
 SEYAM E, HEFZY E. Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome [J]. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, 34(12): 1073-1080.
 RASHIDI B, ABEDIASL J, TEHRANINEJAD E, et al. Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebo-controlled clinical trial [J]. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2011, 59(6): 912-916.
 KAZEROONI T, SHOJAEI-BAGHINI A, DEHBASHI S, et al. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study [J]. Fertility and sterility, 2010, 94(6): 2208-2213.
 SATHYAPALAN T, KILPATRICK E S, COADY A M, et al. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study [J]. The Journal of clinical endocrinology and metabolism, 2009, 94(1): 103-108.
 DULEBA A J, BANASZEWSKA B, SPACZYNSKI R Z, et al. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial %J Fertility and Sterility [J]. 2005, 85(4):
 SEYAM E, AL GELANY S, ABD AL GHANEY A, et al. Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome [J]. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, 34(7): 589-596.
 RAJA-KHAN N, KUNSELMAN A R, HOGEMAN C S, et al. Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial [J]. Fertility and sterility, 2011, 95(5): 1849-1852.
 PUURUNEN J, PILTONEN T, PUUKKA K, et al. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study [J]. The Journal of clinical endocrinology and metabolism, 2013, 98(12): 4798-4807.
 BANASZEWSKA B, PAWELCZYK L, SPACZYNSKI R Z, et al. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment [J]. The Journal of clinical endocrinology and metabolism, 2011, 96(11): 3493-3501.
 GAO L, ZHAO F L, LI S C. Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials [J]. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012, 120(6): 367-375.
 CELIK O, ACBAY O. Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance %J Journal of Endocrinological Investigation [J]. 2012, 35(10):
 MOHER D, LIBERATI A, TETZLAFF J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [J]. Annals of internal medicine, 2009, 151(4): 264-269, w264.
 CUMPSTON M, LI T, PAGE M J, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions [J]. The Cochrane database of systematic reviews, 2019, 10(Ed000142.
 JADAD A R, MOORE R A, CARROLL D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? [J]. Controlled clinical trials, 1996, 17(1): 1-12.
 BERMAN N G, PARKER R A. Meta-analysis: neither quick nor easy [J]. BMC medical research methodology, 2002, 2(10.
 DERSIMONIAN R, LAIRD N. Meta-analysis in clinical trials [J]. Controlled clinical trials, 1986, 7(3): 177-188.
 SATHYAPALAN T, SMITH K A, COADY A M, et al. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study [J]. Annals of clinical biochemistry, 2012, 49(Pt 1): 80-85.
 CLAESSEN B E, GUEDENEY P, GIBSON C M, et al. Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review [J]. Journal of the American Heart Association, 2020, 9(24): e018897.
 WILD R A, CARMINA E, DIAMANTI-KANDARAKIS E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society [J]. The Journal of clinical endocrinology and metabolism, 2010, 95(5): 2038-2049.
 THOMPSON P D, PANZA G, ZALESKI A, et al. Statin-Associated Side Effects [J]. Journal of the American College of Cardiology, 2016, 67(20): 2395-2410.
 ABRUZZESE G A, HEBER M F, FERREIRA S R, et al. Prenatal androgen exposure affects ovarian lipid metabolism and steroid biosynthesis in rats [J]. The Journal of endocrinology, 2020, 247(3): 239-250.
 ORTEGA I, CRESS A B, WONG D H, et al. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells [J]. Biology of reproduction, 2012, 86(1): 1-9.
 MA Y, ZHOU Y, ZHU Y C, et al. Lipophagy Contributes to Testosterone Biosynthesis in Male Rat Leydig Cells [J]. Endocrinology, 2018, 159(2): 1119-1129.
 DIAMANTI-KANDARAKIS E, CHRISTAKOU C, MARINAKIS E. Phenotypes and enviromental factors: their influence in PCOS [J]. Current pharmaceutical design, 2012, 18(3): 270-282.
 SATHYAPALAN T, ATKIN S L. Evidence for statin therapy in polycystic ovary syndrome [J]. Therapeutic advances in endocrinology and metabolism, 2010, 1(1): 15-22.
 TRAVIA D, TOSI F, NEGRI C, et al. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads [J]. The Journal of clinical endocrinology and metabolism, 1995, 80(3): 836-840.
 BERNINI G P, ARGENIO G F, GASPERI M, et al. Effects of long-term simvastatin treatment on testicular and adrenal steroidogenesis in hypercholesterolemic patients [J]. Journal of endocrinological investigation, 1994, 17(4): 227-233.
 JAY R H, STURLEY R H, STIRLING C, et al. Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia [J]. British journal of clinical pharmacology, 1991, 32(4): 417-422.
 SHAWISH M I, BAGHERI B, MUSINI V M, et al. Effect of atorvastatin on testosterone levels [J]. The Cochrane database of systematic reviews, 2021, 1(Cd013211.
 PASCHOU S A, PALIOURA E, IOANNIDIS D, et al. Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS [J]. Endocrine connections, 2017, 6(8): 601-606.
 IDE H, FUJIYA S, AANUMA Y, et al. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones [J]. Clinical therapeutics, 1990, 12(5): 410-420.
 FAUSER B C, TARLATZIS B C, REBAR R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group [J]. Fertility and sterility, 2012, 97(1): 28-38.e25.
 CONWAY G, DEWAILLY D, DIAMANTI-KANDARAKIS E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology [J]. European journal of endocrinology, 2014, 171(4): P1-29.
 IZQUIERDO D, FOYOUZI N, KWINTKIEWICZ J, et al. Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis [J]. Fertility and sterility, 2004, 82 Suppl 3(1193-1197.
 ROCCO M B. Statins and diabetes risk: fact, fiction, and clinical implications [J]. Cleveland Clinic journal of medicine, 2012, 79(12): 883-893.
 KURZTHALER D, HADZIOMEROVIC-PEKIC D, WILDT L, et al. Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects [J]. Reproductive biology and endocrinology : RB&E, 2014, 12(98.
 ATTIA G R, RAINEY W E, CARR B R. Metformin directly inhibits androgen production in human thecal cells [J]. Fertility and sterility, 2001, 76(3): 517-524.
 SATTAR N, PREISS D, MURRAY H M, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials [J]. Lancet (London, England), 2010, 375(9716): 735-742.
 NAKATA M, NAGASAKA S, KUSAKA I, et al. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control [J]. Diabetologia, 2006, 49(8): 1881-1892.
 KAYA C, CENGIZ S D, BERKER B, et al. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study [J]. Fertility and sterility, 2009, 92(2): 635-642.
 PALANIAPPAN M, MENON K M. Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells [J]. Biology of reproduction, 2009, 81(2): 284-292.